Physician

Mary Huerter Wells, MD

According to 2025 Medicare claims, Mary Wells, MD (NPI: 1538508296) practices hematology/oncology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is ONCOLOGY HEMATOLOGY WEST, PC (NPI: 1932178530; TIN: 470754790) and primary practice location at 68114-4108. Wells is affiliated with the CommonSpirit ACO I (ACO ID: A2164), NPG Health Collaborative LLC (ACO ID: A3287), Prairie Vista Care Organization (ACO ID: A3578), Bryan Health Connect ACO, LLC (ACO ID: A4573), Caravan Health ACO 50 LLC (ACO ID: A5160), Main Street Rural Health Maple ACO LLC (ACO ID: A5401), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Wells' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 561 traditional Medicare patients, billed 159,776 HCPCS/CPT codes, and received $2,496,692 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,915 prescription claims across 284 beneficiaries totaling $2,292,837 in drug costs, led by Ibrance (Palbociclib). DME data shows 79 claims. Open Payments data shows 24 records totaling $256,918. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $12,803 to $2,496,692. Similarly, Part D prescription costs have moved sharply higher in recent years, from $70,283 to $2,292,837. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	78	154	$12,803
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	284	42,306	$407,383
2021	341	60,842	$672,724
2022	578	117,815	$1,506,841
2023	568	113,702	$2,201,885
2024	561	159,776	$2,496,692

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	56	561	$70,283
2016	44	618	$56,379
2017	20	114	$2,112
2018	15	25	$1,693
2019	11	24	$940
2020	46	111	$51,505
2021	110	586	$393,778
2022	169	925	$647,439
2023	221	1,114	$597,552
2024	284	1,915	$2,292,837

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	35	$1,989
2022	N/R	57	$1,546
2023	N/R	42	$3,310
2024	N/R	79	$1,451

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	290	840	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	97	114	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	133	169	$12
80053	Blood test, comprehensive group of blood chemicals	89	306	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	106	416	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	24	672	$388,139
Lenalidomide	Lenalidomide	22	616	$319,397
Tagrisso	Osimertinib Mesylate	12	360	$197,123
Brukinsa	Zanubrutinib	12	360	$188,029
Verzenio	Abemaciclib	11	308	$166,101

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	21	$710
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	25	$288
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	16	$282
J8520	Capecitabine, oral, 150 mg	N	N/R	17	$170

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$91	Siemens Medical Solutions USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	20	$256,827	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mary Huerter Wells, MD?

Tedicare shows public-source Medicare data for Mary Huerter Wells, MD (NPI 1538508296), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mary Huerter Wells, MD have ACO affiliation data?

Mary Huerter Wells, MD is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164), NPG Health Collaborative LLC (MSSP, ACO ID A3287), Prairie Vista Care Organization (MSSP, ACO ID A3578), Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Main Street Rural Health Maple ACO LLC (MSSP, ACO ID A5401), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Mary Huerter Wells, MD?

Mary Huerter Wells, MD is linked to ONCOLOGY HEMATOLOGY WEST, PC (billing NPI 1932178530) in the available physician profile data.

Does Mary Huerter Wells, MD have Open Payments data?

Mary Huerter Wells, MD has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.